These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16300644)

  • 1. Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation.
    Lambermon MH; Rappaport RV; McLaurin J
    J Neurochem; 2005 Dec; 95(6):1667-76. PubMed ID: 16300644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
    Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
    Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
    Dong J; Atwood CS; Anderson VE; Siedlak SL; Smith MA; Perry G; Carey PR
    Biochemistry; 2003 Mar; 42(10):2768-73. PubMed ID: 12627941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
    Yoshiike Y; Akagi T; Takashima A
    Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
    Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
    Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
    McLaurin J; Franklin T; Chakrabartty A; Fraser PE
    J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
    Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.
    Orpiszewski J; Benson MD
    J Mol Biol; 1999 Jun; 289(2):413-28. PubMed ID: 10366514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro).
    Schilling S; Lauber T; Schaupp M; Manhart S; Scheel E; Böhm G; Demuth HU
    Biochemistry; 2006 Oct; 45(41):12393-9. PubMed ID: 17029395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: modulating factors in amyloid-beta fibril formation.
    McLaurin J; Yang D; Yip CM; Fraser PE
    J Struct Biol; 2000 Jun; 130(2-3):259-70. PubMed ID: 10940230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.